BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30778902)

  • 21. Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.
    Wolf B; Goebel G; Hackl H; Fiegl H
    BMC Cancer; 2016 Oct; 16(1):821. PubMed ID: 27770790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition.
    Mamessier E; Sylvain A; Bertucci F; Castellano R; Finetti P; Houvenaeghel G; Charaffe-Jaufret E; Birnbaum D; Moretta A; Olive D
    Cancer Res; 2011 Nov; 71(21):6621-32. PubMed ID: 21937679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Invasive breast cancer: the current WHO classification].
    Lebeau A; Kriegsmann M; Burandt E; Sinn HP
    Pathologe; 2014 Feb; 35(1):7-17. PubMed ID: 24496990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High NUP43 expression might independently predict poor overall survival in luminal A and in HER2+ breast cancer.
    Tian C; Zhou S; Yi C
    Future Oncol; 2018 Jun; 14(15):1431-1442. PubMed ID: 29402145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast.
    Narbe U; Sjöström M; Forsare C; Bendahl PO; Alkner S; Leeb-Lundberg LMF; Lövgren K; Rydén L; Ingvar C; Fernö M
    Breast Cancer Res Treat; 2019 Jun; 175(2):305-316. PubMed ID: 30796653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular subtypes of breast carcinoma in Egyptian women: clinicopathological features.
    El-Hawary AK; Abbas AS; Elsayed AA; Zalata KR
    Pathol Res Pract; 2012 Jul; 208(7):382-6. PubMed ID: 22641056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast Cancers of Special Histologic Subtypes Are Biologically Diverse.
    Tadros AB; Wen HY; Morrow M
    Ann Surg Oncol; 2018 Oct; 25(11):3158-3164. PubMed ID: 30094484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemically defined subtypes and outcome of apocrine breast cancer.
    Dellapasqua S; Maisonneuve P; Viale G; Pruneri G; Mazzarol G; Ghisini R; Mazza M; Iorfida M; Rotmensz N; Veronesi P; Luini A; Goldhirsch A; Colleoni M
    Clin Breast Cancer; 2013 Apr; 13(2):95-102. PubMed ID: 23245877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas.
    Kostianets O; Antoniuk S; Filonenko V; Kiyamova R
    Diagn Pathol; 2012 Nov; 7():161. PubMed ID: 23181716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histology and immunophenotype of invasive lobular breast cancer. daily practice and pitfalls.
    Varga Z; Mallon E
    Breast Dis; 2008-2009; 30():15-9. PubMed ID: 19850991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
    Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
    Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
    Sánchez-Muñoz A; Román-Jobacho A; Pérez-Villa L; Sánchez-Rovira P; Miramón J; Pérez D; Sáez MI; de Luque V; Medina L; Ramírez-Tortosa CL; Vicioso L; Medina JA; Ribelles N; Alba E
    Oncology; 2012; 83(4):228-33. PubMed ID: 22907070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
    Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A
    Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer molecular subtypes and associations with clinicopathological characteristics in Iranian women, 2002- 2011.
    Kadivar M; Mafi N; Joulaee A; Shamshiri A; Hosseini N
    Asian Pac J Cancer Prev; 2012; 13(5):1881-6. PubMed ID: 22901141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
    Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
    Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
    Sørlie T; Perou CM; Tibshirani R; Aas T; Geisler S; Johnsen H; Hastie T; Eisen MB; van de Rijn M; Jeffrey SS; Thorsen T; Quist H; Matese JC; Brown PO; Botstein D; Lønning PE; Børresen-Dale AL
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10869-74. PubMed ID: 11553815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
    Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of c-erbB3 protein in primary breast carcinomas.
    Naidu R; Yadav M; Nair S; Kutty MK
    Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.
    Sheffield BS; Kos Z; Asleh-Aburaya K; Wang XQ; Leung S; Gao D; Won J; Chow C; Rachamadugu R; Stijleman I; Wolber R; Gilks CB; Myles N; Thomson T; Hayes MM; Bernard PS; Nielsen TO; Chia SK
    Breast Cancer Res Treat; 2016 Feb; 155(3):483-90. PubMed ID: 26846986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.